(Q47691689)

4 February 2018

http://europepmc.org/abstract/MED/29083538

title

Functional dyspepsia and duodenal eosinophilia: A new model (English)

1 reference

4 February 2018

http://europepmc.org/abstract/MED/29083538

publication date

30 October 2017

1 reference

4 February 2018

http://europepmc.org/abstract/MED/29083538

published in

Journal of Digestive Diseases

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29083538%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29083538%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29083538%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

667-677

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29083538%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

cites work

Gastroduodenal Disorders

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Functional gastroduodenal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Systematic review with meta-analysis: post-infectious functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Functional dyspepsia--symptoms, definitions and validity of the Rome III criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Functional dyspepsia is associated with sleep disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Determinants of symptom pattern in idiopathic severely delayed gastric emptying: gastric emptying rate or proximal stomach dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Abdominal pain is a frequent symptom of gastroparesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Identification of early environmental risk factors for irritable bowel syndrome and dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Prevalence of uninvestigated dyspepsia 8 years after a large waterborne outbreak of bacterial dysentery: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Non-enteric infections, antibiotic use, and risk of development of functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Increased prevalence of autoimmune diseases in functional gastrointestinal disorders: case-control study of 23471 primary care patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Implications of eosinophilia in the normal duodenal biopsy - an association with allergy and functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Anxiety Is Linked to New-Onset Dyspepsia in the Swedish Population: A 10-Year Follow-up Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

21 January 2018

Functional Dyspepsia.

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Impact of psychological stress on irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Polymorphisms of 5-HTT LPR and GNβ3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Genetic factors for functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Migration of eosinophils and CCR2-/CD68-double positive cells into the duodenal mucosa of patients with postinfectious functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Clinical and pathophysiological characteristics of acute-onset functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Duodenal eosinophilia and early satiety in functional dyspepsia: confirmation of a positive association in an Australian cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Functional dyspepsia, H. pylori and post infectious FD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Helicobacter pylori eradication therapy for functional dyspepsia: Systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Symptom patterns in functional dyspepsia and irritable bowel syndrome: relationship to disturbances in gastric emptying and response to a nutrient challenge in consulters and non-consulters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Is there any association between disturbed gastrointestinal visceromotor and sensory function and impaired quality of life in functional dyspepsia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Gastric emptying and antral motility parameters in children with functional dyspepsia: association with symptom severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Acute Anxiety and Anxiety Disorders Are Associated With Impaired Gastric Accommodation in Patients With Functional Dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Prolonged duodenal acid perfusion and dyspeptic symptom occurrence in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Role of duodenal mucosal nerve endings in the acid-induced duodenogastric sensorimotor reflex: effect of benzocaine in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Nutritional habits in functional dyspepsia and its subgroups: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Fatty acid detection during food consumption and digestion: Associations with ingestive behavior and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Non-coeliac gluten or wheat sensitivity: emerging disease or misdiagnosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Dietary and lifestyle factors in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Evidence for neuronal and structural changes in submucous ganglia of patients with functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Increased Duodenal Eosinophil Degranulation in Patients with Functional Dyspepsia: A Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

The role of eosinophils and mast cells in intestinal functional disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Functional dyspepsia is associated with duodenal eosinophilia in an Australian paediatric cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Small bowel homing T cells are associated with symptoms and delayed gastric emptying in functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Dyspepsia and the microbiome: time to focus on the small intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Predictors of the placebo response in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Kyoto global consensus report on Helicobacter pylori gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

American gastroenterological association technical review on the evaluation of dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

A placebo-controlled trial of itopride in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Itopride therapy for functional dyspepsia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Mosapride treatment for functional dyspepsia: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Domperidone: limited benefits with significant risk for sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Efficacy of Mirtazapine in Patients With Functional Dyspepsia and Weight Loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

A survey of pharmacological and nonpharmacological treatment of functional gastrointestinal disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Herbal medicines for the treatment of functional and inflammatory bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Efficacy of acupuncture treatment for functional dyspepsia: A systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Clinical efficacy and pharmacokinetics of montelukast in dyspeptic children with duodenal eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: effect on eosinophil density and activation in relation to pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

The Intestinal Microenvironment and Functional Gastrointestinal Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Effects of Iberogast® on Proximal Gastric Volume, Antropyloroduodenal Motility and Gastric Emptying in Healthy Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Overlap of symptoms of gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Epidemiology of functional dyspepsia and subgroups in the Italian general population: an endoscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1751-2980.12556

Eradication of Helicobacter pylori for non-ulcer dyspepsia

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD002096.PUB2

Identifiers

DOI

10.1111/1751-2980.12556

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29083538%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1 reference